Overview
Markus Niemann practices in Furtwangen Im Schwarzwald, Germany. Mr. Niemann is rated as an Experienced expert by MediFind in the treatment of Endocardial Fibroelastosis. His top areas of expertise are Fabry Disease, Cardiomyopathy, Cardiac Amyloidosis, and Primary Amyloidosis.
His clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Endocardial Fibroelastosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fabry DiseaseMr. Niemann isDistinguished. Learn about Fabry Disease.
- Advanced
- Cardiac AmyloidosisMr. Niemann isAdvanced. Learn about Cardiac Amyloidosis.
- CardiomyopathyMr. Niemann isAdvanced. Learn about Cardiomyopathy.
- Primary AmyloidosisMr. Niemann isAdvanced. Learn about Primary Amyloidosis.
- Experienced
- Aortic Valve StenosisMr. Niemann isExperienced. Learn about Aortic Valve Stenosis.
- Endocardial FibroelastosisMr. Niemann isExperienced. Learn about Endocardial Fibroelastosis.
- Friedreich AtaxiaMr. Niemann isExperienced. Learn about Friedreich Ataxia.
- Heart FailureMr. Niemann isExperienced. Learn about Heart Failure.
- Hereditary AtaxiaMr. Niemann isExperienced. Learn about Hereditary Ataxia.
- Hypertrophic Cardiomyopathy (HCM)Mr. Niemann isExperienced. Learn about Hypertrophic Cardiomyopathy (HCM).